Management Options for Preterm Labour in Canada

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 4, 2004, Pages 339-345

  Leah Klam, Stephanie ^a   Leduc, Line ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Labor; Premature; Tocolytic agents

Indexed keywords

UTERUS SPASMOLYTIC AGENT;

CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MEDICAL SOCIETY; OBSTETRICS; PRACTICE GUIDELINE; PREGNANCY; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CANADA; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; OBSTETRICS; PRACTICE GUIDELINES; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; SOCIETIES, MEDICAL; TOCOLYTIC AGENTS;

EID: 4143144053     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30362-0     Document Type: Article

References (72)

1. Norwitz ER, Robinson JN, Challis JRG. The control of labor. N Engl J Med 1999, 341:660-666.
2. Joseph KS, Kramer MS, Marcoux S, Ohlsson A, Wen SW, Allen A Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998, 339:1434-1439.
3. The Canadian consensus on the use of tocolytics for preterm labour. J Soc Obstet Gynaecol Can 1995, 17:1089-1115. Society of Obstetricians and Gynaecologists of Canada.
4. Preterm labor. Technical Bulletin 206 1995, American College of Obstetrics and Gynecology, ACOG, Washington (DC).
5. National Institutes of Health Consensus Development Conference Statement Antenatal corticosteroids revisited: repeat courses. Obstet Gynecol 2001;98:144-50.
6. Crowley R Prophylactic corticosteroids for preterm birth (Cochrane Review). ln:The Cochrane Library, Issue 3 2002, Update Software, Oxford.
7. Paneth N, Kiely JL, Wallenstein S, Marcus M, Pakter J, Süsser M. Newborn intensive care and neonatal mortality in low-birth-weight infants. N Engl J Med 1982, 307:149-155.
8. Finnström O, Olausson PO, Sedin G, Serenius F, Svenningsen N, Thiringer K, et al. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr 1997, 86:503-511.
9. Lamont RF, Dunlop PDM, Crowley P, Levene MI, Elder MG Comparative mortality and morbidity of infants transferred in utero or postnatal. J Perinat Med 1983, 11:200-203.
10. Gyetvai K, Hannah ME, Hodnett ED Ohlsson ATocolytics for preterm labor: a systematic review. Obstet Gynecol 1999, 94:869-877.
11. Canadian Preterm Labor Investigators GroupTreatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ Assessing the quality of reports on randomized controlled trials: is blinding necessary?. Controlled Clin Trials 1996, 17:1-12.
13. Woolf SH, Battista RN, Anderson GM, Logan AG, Eel W Canadian Task Force on the Periodic Health Exam 1994, xxxvii. Canada Communication Group, Ottawa.
14. Keirse MJNC. Betamimetic tocolytics in preterm labour (Cochrane Review). ln:The Cochrane Library, Issue 2 1995, Update Software, Oxford.
15. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee K-S, Siegler M. Is tocolytic magnesium sulfate associated with increased total paediatric mortality?. Lancet 1997, 350:1517-1518.
16. Mittendorf R, Covert R, Elin R, Pryde PG, Khoshnood B, Lee K-S. Umbilical cord serum ionized magnesium level and total pediatric mortality. Obstet Gynecol 2001, 98:75-78.
17. Mittendorf R, Dambrosia J, Pryde PG, Lee K-S, Gianopoulos JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002, 186:1111-1118.
18. Bennett P, Edwards D Use of magnesium sulphate in obstetrics. Lancet 1997, 350:1491.
19. Beali MH, Edgar BW, Paul AH. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985, 153:854-859.
20. Wilkins L, Lynch L, Mehalek KE, Berkowitz GS, Berkowitz RL Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol 1988, 159:685-689.
21. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987, 156:631-637.
22. Tchilinguirian NG, Najem R, Sullivan GB, Craparo FJ The use of ritodrine and magnesium sulfate in the arrest of premature labor. Int J Gynaecol Obstet 1984, 22:117-123.
23. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990, 163:767-772.
24. Cotton DB, Strassner HT, Hill LM, Schifrin BS, Paul RH. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor: a randomized study. J Reprod Med 1984, 29:92-97.
25. Fox MD, Allbert JR, McCaul JF, Martin RW, McLaughlin BN, Morrison JC. Neonatal morbidity between 34 and 37 weeks' gestation. J Perinatol 1993, 13:349-353.
26. Crowther CA, Hiller JE, Doyle LW Magnesium sulfate for preventing preterm birth in threatened preterm labour (Cochrane Review). ln:The Cochrane Library, Issue 1 2003, Update Software, Oxford.
27. Panter KR, Hannah ME, Amankwah KS, Ohlsson A, Jefferies AL, Farine D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: randomized placebo-controlled trial. Br J Obstet Gynaecol 1999, 106:467-473.
28. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II double-blind study. JPerinatMed 1984, 12:25-29.
29. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980, 136:1014-1019.
30. Morales WJ, Smith SG, Angel JL, O'Brien WF, Knüppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 1989, 74:567-572.
31. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared to magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993, 169:97-102.
32. Goldenberg RL, Davis RO, Baker RC. Indomethacin-induced oligohydramnios. Am J Obstet Gynecol 1989, 160:1196-1197.
33. Moise KJ. The effect of advancing gestational age on the frequency of fetal ductal constriction secondary to maternal indomethacin use. Am J Obstet Gynecol 1993, 168:1350-1354.
34. Van den Veyer IB, Moise KJ, Ou CN, Carpenter RJ. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosis. Obstet Gynecol 1994, 82:500-503.
35. Dudley DKL, Hardie MJ. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 1985, 151:181-184.
36. Norton ME, Merrill J, Cooper B, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993, 329:1602-1607.
37. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol 1994, 170:102-106.
38. Koks CA, Brolmann HA, de Kleine MJ, Manger PA. A randomized comparison of nifedipine and ritodrine for suppression of preterm labour. Eur J Obstet Gynecol Reprod Biol 1998, 77:171-176.
39. Papatsonis DN, Kok JH, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 2000, 95:477-481.
40. Kupfermine M, Lessing JB, Yaron Y, Peyser MR. Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol 1993, 100:1090-1094.
41. Garcia-Velasco JA, Gonzalez Gonzalez A. A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor. Int J Gynaecol Obstet 1998, 61:239-244.
42. Bracero LA, Leikin E, Kirshenbaum N, Tejani N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol 1991, 8:365-369.
43. Ferguson JE II, Dyson DC SchultzT, Stevenson DK. A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol 1990, 163:105-111.
44. Meyer WR, Randall HW, Graves WL Nifedipine versus ritodrine for suppressing preterm labor. J Reprod Med 1990, 35:649-653.
45. Tsatsaris V, Papatsonis DN, Goffinet F, Dekker GA, Carbonne B. Tocoly-sis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001, 97:840-847.
46. Ray JG. Meta-analysis of nifedipine versus beta-sympathomimetic agents for tocolysis during preterm labour. J Obstet Gynaecol Can 1998, 20:259-269.
47. Oei SG, Mol BWJ, de Kleine MJK, Brolmann HAM. Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet Gynecol Scand 1999, 78:783-788.
48. Haghighi L Prevention of preterm delivery: nifedipine or magnesium sulfate. Int J Gynaecol Obstet 1999, 66:297-298.
49. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993, 169:960-964.
50. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour (Cochrane Review). In: The Cochrane Library, Issue 1 2003, Update Software, Oxford.
51. Mari G, Kirshon B, Moise KJ, Lee W, Cotton DB. Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor. Am J Obstet Gynecol 1989, 161:1514-1518.
52. Walker Smith GN., MC McGrath MJ Randomized, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br J Obstet Gynaecol 1999, 106:736-739.
53. Duckitt K, Thornton S Nitric oxide donors for the treatment of preterm labour (Cochrane Review). In The Cochrane Library, Issue 1 2003, Update Software, Oxford.
54. Lees CC, Lojacono A, Thompson C, Danti L, Black RS, Tanzi P Glyceryl trinitrate and ritodrine in tocolysis: an international multi-center randomized study. GTN Preterm Labour Investigation Group. Obstet Gynecol 1999, 94:403-408.
55. El Sayed YY, Riley ET, Holbrook RH, Cohen SE, Chitkara U, Družin ML. Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor. Obstet Gynecol 1999, 93:79-83.
56. Smith GN. The Canadian preterm labour nitroglycerin trial. Available at http://www.perinet.org/GTNTrial.
57. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994, 170:474-478.
58. Goodwin TM, Valenzuela GJ, Silver H, Hayashi R, Creasy GW, Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996, 13:143-146.
59. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille J-C, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000, 182:1173-1183.
60. Moutquin J-M, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000, 182:1191-1199.
61. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001, 108:133-142. The Worldwide Atosiban versus Beta-agonists Study Group.
62. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001, 98:177-185. French/Austalian Atosiban Investigators Group.
63. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001, 80:413-422. The European Atosiban Study Group.
64. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver H, Koltun WD, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000, 182:1184-1190.
65. Sanchez-Ramos L, Kaunitz AM, Gaudier FL Delke 1. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obset Gynecol 1999, 181:484-490.
66. Spisso KR, Harbert GM, Thiagarajah S The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery. Am J Obstet Gynecol 1982, 142:840-845.
67. Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH Acute pulmonary edema in pregnancy. Obstet Gynecol 2003, 101:511-515.
68. Scudiero R, Khoshnood B, Pryde PG, Lee KS, Wall S, Mittendorf R Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol 2000, 96:178-182.
69. Hallak M, Martinez-Poyer J, Kruger ML, Hassan S, Blackwell SC, Sorokin Y. The effect of magnesium sulfate on fetal heart rate parameters: a randomized, placebo-controlled trial. Am J Obstet Gynecol 1999, 181:1122-1127.
70. O'Grady JP, Parker RK, Patel SS. Nitroglycerin for rapid tocolysis: development of a protocol and a literature review. J Perinatol 2000, 1:27-33.
71. Macones GA, Marder SJ, Clothier B, Stamilio DM. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol 2001, 184:264-272.
72. Papatsonis DNM, van Geijn HP, Dekker GA. Nifedipine as a safe and effective tocolytic agent in the treatment of preterm labor. Am J Obstet Gynecol 2000, 181:513-514.